Related Experiment Video
Updated: May 27, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Diuretics in acute kidney injury
Sagar U Nigwekar1, Sushrut S Waikar
1Division of Nephrology, Massachusetts General Hospital, Boston, MA 02114, USA. sagarnigs@gmail.com
Loop diuretics and other agents offer limited benefits for acute kidney injury (AKI) management. Current AKI treatment remains primarily supportive, necessitating further research for effective interventions.
Area of Science:
- Nephrology
- Pharmacology
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) is a prevalent condition in hospitalized patients, contributing to substantial morbidity and mortality.
- The incidence of AKI is rising, yet effective treatments remain elusive, with outcomes largely unchanged despite clinical advancements.
- Current management of AKI is predominantly supportive, lacking interventions with proven efficacy.
Purpose of the Study:
- To review the pharmacology and evidence for loop diuretics in AKI management.
- To examine evidence for other diuretic and natriuretic agents in AKI prevention and treatment.
- To provide guidance for clinical decision-making in AKI management.
Main Methods:
- Review of pharmacological properties of diuretics.
- Analysis of experimental and clinical evidence for loop diuretics in AKI.
- Evaluation of evidence for thiazide diuretics, mannitol, fenoldopam, and natriuretic peptides in AKI.
Main Results:
- Loop diuretics have not demonstrated convincing benefits in clinical studies for AKI prevention or treatment.
- Evidence for other agents like thiazide diuretics, mannitol, fenoldopam, and natriuretic peptides in AKI is also limited.
- Current clinical practice for AKI remains largely supportive.
Conclusions:
- No current diuretic or natriuretic agent has shown definitive benefits for AKI.
- Further research is needed to identify effective interventions for AKI.
- Clinical decisions in AKI management should consider the limited evidence for pharmacological agents.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

